Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/27/25 16:05 | 10/23/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Finn Patrick John | CA | O | P,COO | 25 | S | -4,138 | 38.27 | 0 | -108 | 274 | D | |||||||||||||||
10/10/25 16:05 | 10/8/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Laponis Adam | CA | O | CFO | 11 | S.m | -1,254 | 38.56 | 0 | -33 | 110 | D | |||||||||||||||
10/8/25 16:05 | 10/6/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Leproust Emily M. | CA | DO | CEO | 29 | S.d | -5,529 | 39.37 | 0 | -140 | 675 | D | |||||||||||||||
10/8/25 16:05 | 10/6/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Werner Robert F. | CA | O | Chief Ac | 20 | S.m | -453 | 38.02 | 0 | -12 | 53 | D | |||||||||||||||
10/8/25 16:05 | 10/6/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Green Paula | CA | O | SVP of H | 29 | S | -1,582 | 39.36 | 0 | -40 | 134 | D | |||||||||||||||
10/8/25 16:05 | 10/6/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Cho Dennis | CA | O | See Rema | 36 | S | -1,020 | 38.50 | 0 | -27 | 114 | D | |||||||||||||||
2/11/25 16:05 | 2/7/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Chess Robert | CA | D | 4 | S.d | -758 | 50.39 | 0 | -15 | 64 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |